CR Stock Analysis: Crane | NYSE
Specialty Industrial Machinery | NYSE, USA | Market Cap: 12.568m USD | 12M Return: 12.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 103M
EPS Trend: 42.4%
Qual. Beats: 4
Rev. Trend: 84.2%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 3.2 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Crane Company (NYSE: CR) is a U.S.-based industrial manufacturer of engineered products operating across two main segments. Its Aerospace & Advanced Technologies segment supplies OEM and aftermarket components for commercial aerospace, military aerospace, defense, and space markets, including pressure sensors for engine control, aircraft braking systems, defense and space power conversion solutions, and lubrication systems. The Process Flow Technologies segment manufactures process and commercial valves, pumps, valve positioning and control systems, vacuum insulated pipe systems, and valve diagnostic and calibration equipment. The company serves customers in the U.S., Canada, the U.K., Continental Europe, and other international markets. Originally founded in 1855 and headquartered in Stamford, Connecticut, Crane operates a diversified, B2B-focused business model serving highly regulated aerospace, defense, and industrial process end-markets, which typically involve long product certification cycles and recurring aftermarket service revenue.
- Commercial aerospace aftermarket recovery fuels segment growth
- Defense spending surge lifts Aerospace & Electronics backlog
- Process Flow Technologies margins expand on price actions
| Net Income: 326.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -3.64 > 1.0 |
| NWC/Revenue: 39.34% < 20% (prev 32.05%; Δ 7.29% < -1%) |
| CFO/TA 0.08 > 3% & CFO 311.6m > Net Income 326.6m |
| Net Debt (876.2m) to EBITDA (508.5m): 1.72 < 3 |
| Current Ratio: 2.85 > 1.5 & < 3 |
| Outstanding Shares: last quarter (58.7m) vs 12m ago 0.34% < -2% |
| Gross Margin: 41.60% > 18% (prev 40.84%; Δ 0.76% > 0.5%) |
| Asset Turnover: 73.24% > 50% (prev 84.95%; Δ -11.72% > 0%) |
| Interest Coverage Ratio: 18.76 > 6 (EBIT TTM 442.7m / Interest Expense TTM 23.6m) |
| A: 0.24 (Total Current Assets 1.48b - Total Current Liabilities 520.2m) / Total Assets 4.05b |
| B: 0.39 (Retained Earnings 1.58b / Total Assets 4.05b) |
| C: 0.13 (EBIT TTM 442.7m / Avg Total Assets 3.34b) |
| D: 1.08 (Book Value of Equity 2.10b / Total Liabilities 1.95b) |
| Altman-Z'' = 4.85 = AA |
| DSRI: 0.98 (Receivables 493.8m/460.7m, Revenue 2.44b/2.23b) |
| GMI: 0.98 (GM 40.84% / 41.60%) |
| AQI: 1.46 (AQ_t 0.54 / AQ_t-1 0.37) |
| SGI: 1.10 (Revenue 2.44b / 2.23b) |
| TATA: 0.00 (NI 326.6m - CFO 311.6m) / TA 4.05b) |
| Beneish M = -2.72 (Cap -4..+1) = A |
As of July 09, 2026, the stock is trading at USD 214.13 with a total of 419,398 shares traded. Over the past week, the price has changed by -4.01%, over one month by +11.10%, over three months by +16.54% and over the past year by +12.38%.
Current recommended Stop Loss: 201.00 (which is 6.1% or 2.1 ATR below the current price).
Crane has received a consensus analysts rating of 4.22. Therefore, it is recommended to buy CR.
- StrongBuy: 5
- Buy: 2
- Hold: 1
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 221.9 | 3.6% |
P/E Trailing = 39.8608
P/E Forward = 32.2581
P/S = 5.1427
P/B = 5.9935
P/EG = 2.9581
Revenue TTM = 2.44b USD
EBIT TTM = 442.7m USD
EBITDA TTM = 508.5m USD
Long Term Debt = 1.19b USD (from longTermDebt, last quarter)
Short Term Debt = 22.3m USD (from shortTermDebt, last quarter)
Debt = 1.23b USD (from shortLongTermDebtTotal, last quarter) + Leases 16.7m
Net Debt = 876.2m USD (calculated: Debt 1.23b - CCE 355.4m)
Enterprise Value = 13.4b USD (12.6b + Debt 1.23b - CCE 355.4m)
Interest Coverage Ratio = 18.76 (Ebit TTM 442.7m / Interest Expense TTM 23.6m)
EV/FCF = 51.39x (Enterprise Value 13.4b / FCF TTM 261.6m)
FCF Yield = 1.95% (FCF TTM 261.6m / Enterprise Value 13.4b)
FCF Margin = 10.70% (FCF TTM 261.6m / Revenue TTM 2.44b)
Net Margin = 13.36% (Net Income TTM 326.6m / Revenue TTM 2.44b)
Gross Margin = 41.60% ((Revenue TTM 2.44b - Cost of Revenue TTM 1.43b) / Revenue TTM)
Gross Margin QoQ = 40.39% (prev 41.58%)
Tobins Q-Ratio = 3.32 (Enterprise Value 13.4b / Total Assets 4.05b)
Interest Expense / Debt = 1.92% (Interest Expense 23.6m / Debt 1.23b)
Taxrate = 23.53% (98.6m / 419.1m)
NOPAT = 338.5m (EBIT 442.7m * (1 - 23.53%))
Current Ratio = 2.85 (Total Current Assets 1.48b / Total Current Liabilities 520.2m)
Debt / Equity = 0.59 (Debt 1.23b / totalStockholderEquity, last quarter 2.10b)
Debt / EBITDA = 1.72 (Net Debt 876.2m / EBITDA 508.5m)
Debt / FCF = 3.35 (Net Debt 876.2m / FCF TTM 261.6m)
Total Stockholder Equity = 2.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.79% (Net Income 326.6m / Total Assets 4.05b)
RoE = 16.30% (Net Income TTM 326.6m / Total Stockholder Equity 2.00b)
RoCE = 13.85% (EBIT 442.7m / Capital Employed (Equity 2.00b + L.T.Debt 1.19b))
RoIC = 9.87% (NOPAT 338.5m / Invested Capital 3.43b)
WACC = 9.56% (E(12.6b)/V(13.8b) * Re(10.35%) + D(1.23b)/V(13.8b) * Rd(1.92%) * (1-Tc(0.24)))
Discount Rate = 10.35% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 79.57 | Cagr: 0.84%
[DCF] Terminal Value 71.13% ; FCFF base≈262.9m ; Y1≈261.3m ; Y5≈271.2m
[DCF] Fair Price = 45.59 (EV 3.51b - Net Debt 876.2m = Equity 2.63b / Shares 57.7m; r=9.56% [WACC]; 5y FCF grow -1.21% → 2.50% )
EPS Correlation: 42.35 | EPS CAGR: 6.96% | SUE: 4.0 | # QB: 4
Revenue Correlation: 84.21 | Revenue CAGR: 9.34% | SUE: 1.52 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.66 | Chg30d=+0.27% | Revisions=+62% | Analysts=7
EPS next Quarter (2026-09-30): EPS=1.76 | Chg30d=+0.15% | Revisions=+0% | Analysts=7
EPS current Year (2026-12-31): EPS=6.80 | Chg30d=+0.28% | Revisions=+0% | GrowthEPS=+12.4% | GrowthRev=+24.4%
EPS next Year (2027-12-31): EPS=7.62 | Chg30d=+0.40% | Revisions=-25% | GrowthEPS=+12.0% | GrowthRev=+5.8%
[Analyst] Revisions Ratio: +31% (up=7, down=3)